Most Read Articles
Audrey Abella, 15 May 2020
In adults with atrial fibrillation (AF) after percutaneous coronary intervention (PCI), dual therapy (direct oral anticoagulant [DOAC] + P2Y12 inhibitor) reduces the risk of bleeding compared with triple therapy (vitamin K antagonist [VKA] + DAPT* [aspirin and P2Y12 inhibitor]), a meta-analysis has shown. However, its effects on the risks of mortality and ischaemic endpoints** remain unclear.
09 May 2020
Use of aspirin during the implantation window of the menstrual cycle appears to increase fecundability, reveals a recent study.
Rachel Soon, 08 Apr 2020

Guidelines for local pharmacists on what actions to take during the COVID-19 pandemic have been issued by the Malaysian Pharmaceutical Society (MPS).

Roshini Claire Anthony, 2 days ago

The use of a vaginal cleansing intervention prior to Caesarean delivery reduced the incidence of surgical site infections (SSIs), according to a study presented at ACOG 2020. However, the addition of intravenous (IV) azithromycin prophylaxis had no added impact on SSI rates. 

Multimodal analgesia better than opioids at dulling pain after penile implants

07 Mar 2020

Multimodal analgesia (MMA) regimens effectively decrease postoperative pain in patients receiving inflatable penile prosthesis (IPP) implants, a recent study has found.

The study included 203 patients undergoing IPP implantation, of whom 103 (mean age, 62.9±8.8 years) were given an MMA protocol consisting of preoperative and postoperative doses of acetaminophen, gabapentin, and meloxicam or celecoxib, with intraoperative administrations of dorsal and pudendal nerve blocks. The remaining 100 patients (mean age, 64.3±10.1 years) were set as opioid-only controls.

The MMA regimen appeared to be superior. Median visual analogue scale (VAS) scores were significantly lower relative to the opioid group in the postanaesthesia care unit (PACU; 0.0 vs 2.0; p=0.01) and at postoperative day 0 (3.0 vs 4.0; p=0.001) and day 1 (3.0 vs 4.3; p=0.04).

Similarly, fewer narcotics were needed in the MMA vs the opioid group while in the PACU (0.0 vs 4.0 total morphine equivalents; p=0.001) and at postoperative day 0 (7.5 vs 12.5 total morphine equivalents; p<0.001) and day 1 (7.5 vs 13.5 total morphine equivalents; p=0.01).

These advantages extended until the time of discharge, at which point patients treated with the MMA protocol were prescribed significantly fewer narcotics (p<0.001) and were less likely to need refills (p=0.001) than their opioid comparators.

Both treatments were comparably tolerated, with no pain medication-related side effects reported in either arm. This included manifestations such as visual changes, haematomas and acute kidney injuries. The rates of postoperative urinary retention (8.7 percent vs 12.5 percent; p=0.49) and pruritis (0.9 percent vs 3.1 percent; p=0.35) also did not differ between groups.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 15 May 2020
In adults with atrial fibrillation (AF) after percutaneous coronary intervention (PCI), dual therapy (direct oral anticoagulant [DOAC] + P2Y12 inhibitor) reduces the risk of bleeding compared with triple therapy (vitamin K antagonist [VKA] + DAPT* [aspirin and P2Y12 inhibitor]), a meta-analysis has shown. However, its effects on the risks of mortality and ischaemic endpoints** remain unclear.
09 May 2020
Use of aspirin during the implantation window of the menstrual cycle appears to increase fecundability, reveals a recent study.
Rachel Soon, 08 Apr 2020

Guidelines for local pharmacists on what actions to take during the COVID-19 pandemic have been issued by the Malaysian Pharmaceutical Society (MPS).

Roshini Claire Anthony, 2 days ago

The use of a vaginal cleansing intervention prior to Caesarean delivery reduced the incidence of surgical site infections (SSIs), according to a study presented at ACOG 2020. However, the addition of intravenous (IV) azithromycin prophylaxis had no added impact on SSI rates.